Surgical Injury to Surge Global Sick Sinus Syndrome Treatment Market

Sick Sinus is a rare heart rhythm disorder caused due to dysfunction of sinus node. It usually affects people above the age of 50, however sometimes it also affects the children due to various factors. One of the factors that causes sick sinus syndrome is surgical injury, owing to the expansion of the global sick sinus treatment market in the future.

Get Sample Copy of this Report @

New Implant to Intensify Sick Sinus Syndrome Treatment Market

The researchers of the Leiden University Medical Centre (LUMC) collaborated with Delft University of Technology to find a way to reset the racing heart. Together they have developed an implant that with LED device. This device was coined using gene therapy to initiate light sensitive proteins into the heart. This flash from the light enables the heart to send an electric current in itself and halt the arrhythmia (an abnormal racing of hear). This helps in restoring the normal heart rhythm automatically and instantly. The new gene therapy based implant is projected to provide growth to the global sick sinus syndrome treatment market.

World’s Smallest Pacemaker to Fuel Sick Sinus Syndrome Market

Although, heart rhythm disorder is an uncommon disorder, it has been rising over the past few years. So, in 2017, the world’s smallest pacemaker was introduced in the form of miniature micra transcatheter pacing system. (MTPS). It can be implanted via minimally invasive procedures. This does not require use of leads, it is gaining popularity among the patients due to its minimal invasiveness and long lasting batteries. This offers some relief to patients to deal with heart rhythm disorder, owing to the expansion of the global sick sinus syndrome market. This is expected to be the most sought after treatment line in the future for sick sinus syndrome, a condition where the natural pacemaker of the heart does not function properly.

Read Comprehensive Overview of Report @

Rising Geriatric Population to Fuel Demand for Sick Sinus Syndrome Treatments

San Francisco, California, Sept 01, 2017: A new market study by TMR Research states that the global market for sick sinus syndrome treatment has been undergoing a phase of significant growth and is projected to continue on this path over the next few years. The research report, titled “Sick Sinus Syndrome Treatment Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017–2025,” offers a detailed and unbiased assessment of this market based on its current and historical performance. The trends, driving forces, obstructions, challenges, opportunities, and the future scope of this market have also been thoroughly evaluated while performing this research.

According to the research study, the increasing base of the geriatric population is the key factor behind the growth of the global market for sick sinus syndrome treatment. Apart from this, the rising pediatric population is also propelling this market substantially as children are more susceptible to sick sinus syndrome. Researchers predict these trends to remain boosting this market over the next few years, notes the research study.

The global market for sick sinus syndrome treatments reports its presence across Europe, Asia Pacific (APAC), North America, and the Rest of the World (RoW). Of these, North America leads the overall market with a number of lucrative opportunities as a large portion the population in the U.S. suffers from sick sinus syndrome and opt for the implantation of atrial or dual-chamber pacemakers. The presence of a favorable reimbursement system is another factor that is boosting this regional market significantly.

North America is closely followed by Europe in terms of the potential it holds in the market for sick sinus syndrome treatments. The U.K., Spain, Germany, France, and Italy, have emerged as the prime domestic markets for sick sinus syndrome treatments in Europe, thanks to the burgeoning base of the geriatric population in these years, which is also slated to push this regional market upward in the years to come. The markets in Asia Pacific and the Rest of the World are also projected to record substantial growth on the grounds of the swiftly advancing medical and healthcare infrastructure in emerging economies in this region over the forecast period, states the market report.

The research report also present a competitive analysis of the global marked for sick sinus syndrome treatments. As per the study, Boston Scientific Corp., Medtronic Inc., GlaxoSmithKline, St. Jude Medical Inc., Sorin Group, Biotronik GmbH & Co. KG, Novartis AG, and Pfizer Ltd. are key providers of sick sinus syndrome treatments across the world.

Click on the link below to request a sample copy of the report